Additional file 1: of Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus SandimmunÂŽ Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants

Figure S1. Inclusion and exclusion criteria. (DOCX 27 kb)